NEUROGENE INC (NGNE) Stock Cash Flow
NASDAQ:NGNE - Nasdaq - US64135M1053 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -75.14M | -36.32M | -57.56M | -60.69M | -33.28M | |||
| Depreciation Amortization | 3.19M | 3.26M | 1.56M | 1.31M | 785.00K | |||
| Change In Working Capital | -5.96M | -4.02M | 885.00K | -700.00K | 966.00K | |||
| Interest Paid | 12.00K | 12.00K | N/A | N/A | N/A | |||
| Other non cash items | 7.31M | -14.34M | 9.50M | 12.53M | 6.95M | |||
| OPERATING CASH FLOW | -70.60M | -51.42M | -45.61M | -47.56M | -24.57M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -808.00K | -321.00K | -1.11M | -3.26M | -2.22M | |||
| Other Investing Activity | -124.45M | 25.96M | -58.02M | N/A | 0.00 | |||
| INVESTING CASH FLOW | -125.26M | 25.64M | -59.13M | -3.26M | -2.22M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -52.00K | -29.00K | -55.00K | -51.00K | -49.00K | |||
| Stock Issued/Repurchased | 1.68M | 92.51M | 216.00K | 783.00K | 77.54M | |||
| Other Financing Activity | 182.45M | N/A | N/A | 0.00 | -355.00K | |||
| FINANCING CASH FLOW | 184.07M | 92.48M | 161.00K | 732.00K | 77.14M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | -11.79M | 66.70M | -104.58M | -50.09M | 50.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -70.60M | -51.42M | -45.61M | -47.56M | -24.57M | |||
| Capital Expenditure | -808.00K | -321.00K | -1.11M | -3.26M | -2.22M | |||
| FREE CASH FLOW | -71.41M | -51.74M | -46.72M | -50.82M | -26.79M | |||
All data in USD